U.S., Oct. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07207408) titled 'Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age' on Oct. 02.
Brief Summary: This study will evaluate the immunogenicity, safety, and tolerability of rF1V-1018 vaccine
Study Start Date: Sept. 11
Study Type: INTERVENTIONAL
Condition:
Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersenia Pestis
Intervention:
BIOLOGICAL: rF1V-1018
Regimen 1
BIOLOGICAL: rF1V-1018
Regimen 2
BIOLOGICAL: rF1V-1018
Regimen 3
BIOLOGICAL: rF1V-1018
Regimen 4
BIOLOGICAL: rF1V-1018
Regimen 5
BIOLOGICAL: rF1V-1018
Regimen 6
Recruitment Status: RECRUITING
Sponsor: Dynavax Technolo...